Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs LOGSX overlap: 31% of top holdings shared

Bottom line

How much do XLV and LOGSX overlap?

31% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 51.4% of XLV's assets and 50.3% of LOGSX's. They share a meaningful core but differ in the rest of the portfolio.

XLV holds far more positions (65 vs 28), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

XLVLOGSX
Weight overlap (top 25)31%
Shared holdings13
Weight in shared holdings51.4%50.3%
Total positions6528
Expense ratio0.08%1.04%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings XLV and LOGSX have in common

Holding% of XLV% of LOGSXOverlap
Eli Lilly & Co16.51%1.99%1.99%
Johnson & Johnson10.64%3.77%3.77%
Merck & Co Inc5.52%3.16%3.16%
Amgen Inc3.40%4.86%3.40%
Gilead Sciences Inc2.73%3.50%2.73%
Intuitive Surgical Inc2.45%2.99%2.45%
Vertex Pharmaceuticals Inc2.19%3.26%2.19%
Bristol-Myers Squibb Co2.05%4.02%2.05%
McKesson Corp1.58%4.53%1.58%
Cigna Group/The1.27%3.46%1.27%
Regeneron Pharmaceuticals Inc1.08%4.43%1.08%
Cardinal Health Inc0.97%5.86%0.97%
Cencora Inc0.96%4.46%0.96%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. AbbVie Inc — 7.74%
  2. UnitedHealth Group Inc — 6.57%
  3. Thermo Fisher Scientific Inc — 3.24%
  4. Abbott Laboratories — 2.75%
  5. Pfizer Inc — 2.39%
  6. CVS Health Corp — 2.30%
  7. Danaher Corp — 2.09%
  8. Stryker Corp — 1.89%
  9. Medtronic PLC — 1.75%
  10. Elevance Health Inc — 1.46%
  11. Boston Scientific Corp — 1.10%
  12. HCA Healthcare Inc — 1.05%

Only in LOGSX

  1. N/a — 6.91%
  2. Jazz Pharmaceuticals Plc — 5.77%
  3. United Therapeutics Corp — 5.11%
  4. Exelixis Inc — 4.95%
  5. Lantheus Holdings Inc — 4.68%
  6. Novartis Ag — 4.67%
  7. National Healthcare Corp — 3.87%
  8. Medpace Holdings Inc — 3.69%
  9. Incyte Corp — 3.30%
  10. Medtronic Plc — 3.01%
  11. Novo Nordisk A/s — 2.51%
  12. Labcorp Holdings Inc — 2.29%

Asset mix

Asset typeXLVLOGSX
Stocks99.7%97.2%
Repurchase agreements—6.9%
Cash & short-term funds0.3%1.6%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryXLVLOGSX
US97.9%89.7%
IE2.1%8.8%
CH—4.7%
DK—2.5%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do XLV and LOGSX overlap?
About 31% by weight. 13 securities appear in both funds' top 25 holdings; they make up 51.4% of XLV's assets and 50.3% of LOGSX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do XLV and LOGSX have in common?
The largest shared holdings are Johnson & Johnson, Amgen Inc, Merck & Co Inc, Gilead Sciences Inc, Intuitive Surgical Inc.
Should I own both XLV and LOGSX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, XLV or LOGSX?
XLV is broader, with 65 positions versus 28 for LOGSX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.